Get startedLog in
    Picture of Gfc Life Science Co logo

    388610 — Gfc Life Science Co Income Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapSucker Stock
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Gfc Life Science Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M
    Source:Annual Audited AccountsAnnual Audited AccountsARSARS
    Standards:
    KAS
    KAS
    KAS
    IFRS
    Status:FinalFinalFinalFinal
    Revenue
    Total Revenue13,73714,15815,30116,805
    Cost of Revenue
    Gross Profit6,4866,2046,7667,877
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Unusual Expense / Income
    Total Operating Expenses12,40113,55614,56915,100
    Operating Profit1,3366037321,705
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes1,657234469-5,733
    Provision for Income Taxes
    Net Income After Taxes1,6413271,437-5,947
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income1,6173271,437-5,947
    Adjustments to Net Income
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Dilution Adjustment
    Diluted Net Income1,6173271,367-5,947
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS49279.5320-1,862
    Dividends per Share